PROBIOTIX HEALTH LS-05 Financial Flexibility Index
PROBIOTIX HEALTH LS-05 financial flexibility index. PROBIOTIX HEALTH LS-05 (X90) has a Financial Flexibility Index of -4.13x as of December 2024. Free cash flow of €-1.05 Million (operating CF €-1.06 Million minus capex €10.00K) represents -4% of total liabilities (€254.00K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of PROBIOTIX HEALTH LS-05 (2022–2024)
Financial flexibility index of PROBIOTIX HEALTH LS-05 from 2022 to 2024. Historical Financial Flexibility Index trend for PROBIOTIX HEALTH LS-05 across 3 annual periods. Explore X90 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
PROBIOTIX HEALTH LS-05 Financial Flexibility Index by Year (2022–2024)
PROBIOTIX HEALTH LS-05 financial flexibility index by year from 2022 to 2024. Year-by-year free cash flow to debt coverage for PROBIOTIX HEALTH LS-05. For the full cash flow conversion analysis, see PROBIOTIX HEALTH LS-05 (X90) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.13x | €-1.05 Million | €-1.06 Million | €254.00K | ▼ -1013.4% |
| 2023 | -0.37x | €-238.00K | €-238.00K | €641.00K | ▲ +78.0% |
| 2022 | -1.69x | €-591.94K | €-638.02K | €350.91K | — |